Prevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria

dc.contributor.authorAyed, Z.
dc.contributor.authorHouinato, Dismand
dc.contributor.authorHocine, M.
dc.contributor.authorRanger-Rogez, S.
dc.contributor.authorDenis, François
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued1995
dc.description.abstractSerologic markers of hepatitis B (AgHBs, anti-HBc) and hepatitis C (anti-HCV) are investigated in 1,112 apparently healthy blood donors and 715 pregnant women in Algeria. Data of this study have shown a low prevalence of HCV and confirm that this country belongs to the middle endemic area for HBV. Indeed the anti-HCV were detected in 0.18 % of blood donors and 0.19 % of pregnant women. The AgHBs were observed in 3.6 % of blood donors and 1.6 % of pregnant women, anti-HBc antibodies were found in 13 % of blood donors and 11.1 % of pregnant women.
dc.identifier.otherBECDB-2518
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/2553
dc.language.isofr
dc.relation.ispartofBulletin De La Societe De Pathologie Exotique (1990)
dc.subjectPrevalence
dc.subjectserum markers
dc.subjecthepatitis B and C
dc.subjectpregnant women
dc.subjectAlgeria]
dc.titlePrevalence of serum markers of hepatitis B and C in blood donors and pregnant women in Algeria
dc.typeArticle

Files

Collections